PILLPHARM
ActivePILLPHARM has been active since 2010 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €53k and a net result of €25k. Equity remains stable across the filed fiscal years (±2.4% per year). Its solvency ranks better than 73% of 18237 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.7% (low).
Checked score
Score 2025
89
/ 100
Excellent
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability100▲+98
Solvency87▲+13
Growth58▲+26
Track record100
Bankruptcy probability, 12 months
0.7%
Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €4.5k at 30 days acceptable
Liquidity ample (current ratio 18.9 against 33.15 in 2024; short-term debt: 5.2% and cash: 48.7% of total assets), and 38.1% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Seven signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Sector 47
higher
← fewer bankruptcies
more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
61.9%
Return on assets
28.9%
Age of the figures
12 mo
neutral · Latest accounts filed on time
The financial year that closed on 30-09-2025 was due by 30-04-2026 and was filed on 12-12-2025, 139 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
139 d early
2024
20 d early
2023
34 d early
2022
19 d early
2021
5 d early
2020
7 d early
2019
2 d early
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 30-09-2026 and is due by 30-04-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
21-09-2026 today30-09-2026 close30-04-2027 deadline
Financials · fiscal year 2025, micro schema
Equity
€53k▲ 87.6%
2024 · €28k
2018: €62k
2019: €60k
2020: €57k
2021: €54k
2022: €58k
2023: €58k
2024: €28k
2018 → 2025
Total assets
€86k▲ 47.3%
2024 · €58k
2018: €110k
2019: €92k
2020: €88k
2021: €85k
2022: €93k
2023: €91k
2024: €58k
2018 → 2025
Net result
€25k
2024 · €-30k
2018: €17k
2019: €-2k
2020: €-3k
2021: €-3k
2022: €4k
2023: €58
2024: €-30k
2018 → 2025
Working capital
€80k▲ 45.2%
2024 · €55k
2018: €85k
2019: €86k
2020: €79k
2021: €78k
2022: €79k
2023: €82k
2024: €55k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€54k-€58k▲ 7.6%€58k▲ 0.1%€28k▼ 51.0%€53k▲ 87.6%
Operating result€-5k-€7k€-2k€9k€27k▲ 215%
Net result€-3k-€4k€58▼ 98.6%€-30k€25k
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
After the dip in 2023 the operating result has climbed two years in a row; 2025 is 215% above 2024 and is the highest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €86k
Fixed assets
€2k▲ 5.7%
Current assets
€84k▲ 48.7%
Equity and liabilities €86k
Equity
€53k▲ 87.6%
Provisions
€28k=
Debt
€5k▲ 140%
The debt ratio rises from 3.3% to 5.5%. Equity and debt are higher.
Key figures and ratios
EBITDA
€28k▲
2024 · €11k
Cash flow
€26k▲
2024 · €-27k
Solvency
61.9%▲
2024 · 48.6%
Current ratio
18.90▼
2024 · 33.15
Quick ratio
18.90▼
2024 · 33.15
Debt / equity
0.09▲
2024 · 0.07
ROE
46.7%▲
2024 · -104.0%
ROA
28.9%▲
2024 · -50.5%
Interest coverage
127.66▲
2024 · 0.27
Debt
€5k▲
2024 · €2k
Debt ≤ 1 year
€4k▲
2024 · €2k
Income taxes
€4k▲
2024 · €308
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€58k€86k▲
Fixed assets21/28€2k€2k▲
Tangible fixed assets22/27€918€1k▲
Furniture and vehicles24€918€1k▲
Financial fixed assets28€1k€1k=
Current assets29/58€57k€84k▲
Amounts receivable within one year40/41€40k€42k▲
Trade receivables40€9k€10k▲
Other amounts receivable41€30k€32k▲
Cash at bank and in hand54/58€17k€42k▲
Equity and liabilities
Total equity and liabilities10/49€58k€86k▲
Equity10/15€28k€53k▲
Contributions10/11€6k€6k=
Reserves13€9k€34k▲
Non-distributable reserves130/1€0-
Reserves not available under the articles1311€0-
Distributable reserves133€9k€34k▲
Profit (loss) carried forward14€13k€13k=
Provisions and deferred taxes16€28k€28k=
Provisions for liabilities and charges160/5€28k€28k=
Pensions and similar obligations160€28k€28k=
Amounts payable17/49€2k€5k▲
Amounts payable within one year42/48€2k€4k▲
Trade debts44€442€460▲
Suppliers440/4€442€460▲
Taxes, remuneration and social security45€1k€4k▲
Taxes450/3€1k€4k▲
Accrued charges and deferred income492/3€250€250=
Income statement
Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€2k€977▼
Other operating charges640/8€1k€1k▼
Non-recurring operating charges66A-€80
Gross operating margin9900€12k€29k▲
Operating profit (loss)9901€9k€27k▲
Financial income75/76B€2k€2k▲
Recurring financial income75€2k€2k▲
Financial charges65/66B€40k€221▼
Recurring financial charges65€40k€221▼
Profit (loss) for the period before taxes9903€-29k€29k▲
Income taxes67/77€308€4k▲
Profit (loss) for the period9904€-30k€25k▲
Profit (loss) for the period to be appropriated9905€-30k€25k▲
Appropriation of the result
Profit (loss) to be appropriated9906€13k€38k▲
Profit (loss) brought forward from the previous period14P€43k€13k▼
Transfer to equity691/2-€25k
To other reserves6921-€25k
The notes to these accounts (10 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2025
12-12
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
30-09
Financial
Back to profitnet €25k
Net result €25k after one loss-making year.
10-04
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
30-09
Financial
Weakest financial yearnet €-30k ▼50643%
Net result drops to €-30k, the lowest in the series; recovery starts the following year.
27-03
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
11-04
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
2022
30-09
Financial
Back to profitnet €4k
Net result €4k after 3 loss-making years.
25-04
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema
2021
23-04
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema
2020
28-04
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema
2019
30-09
Financial
Liquidity quadruplescurrent ratio 21.61
Current ratio from 5.31 to 21.61; short-term debt falls from €20k to €4k.
10-04
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema
2018
27-03
NBB filing
Annual accounts filed
fiscal year 2017 · micro schema
2017
11-05
NBB filing
Annual accounts filed
fiscal year 2016 · full schema · 11 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
3 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Mouscron · 1 establishment unit since 2010
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Dorpstraat(L) 77700 MouscronGround area
181 m²
Building footprint
68 m²
Volume, LiDAR
676 m³
Parcel 54007B1227/00_000, Wallonia · tallest building 11.5 m, ±3 floors. Linked by address, not a title deed.
1 establishment unit
PILLPHARM
since 20102.189.564.271
1 parcel
Wallonia
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 54007B1227/00_000 | Wallonia | 181 m² | 1 · 68 m² | 11.5 m · 3 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Recognitions · licences · registrations
Food safety, FASFC
1 siteMouscron/Moeskroen2.189.564.271
Legal Entity Identifier
25490042N856AVDHTK61
Similar companies · same sector, comparable size
PHARMACIE DE LA DRÊVE
BE 0421.582.883
Seneffe · Eq €53k
ELIAM
BE 1000.694.461
Hasselt · Eq €53k
Pharmacie de Stoumont
BE 0454.899.712
Stoumont · Eq €53k
KIDEPHAR
BE 0452.044.843
Aubange · Eq €53k
APOTHEEK DE WILDE ZEE
BE 0435.512.776
Antwerpen · Eq €53k
Of 5,222 companies in sector 47730 we hold annual accounts for 3,861. 2,831 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded15-04-2010
Fiscal year end30-09
Activities, NACEBEL
47730Retail sale of pharmaceutical products
74201Photography, excluding press photography
Sources
Crossroads Bank for EnterprisesNational Bank · 15 filingsAddress and cadastre registers
Data from official sources, last processed on 21-09-2026. Scores and ratios are computed by Checked and are not a credit decision.